Pink Sheet Podcast: US FDA And Trump’s Reforms, CDER Director Parting Comments, 2024 Approval Trends

 
• By Derrick Gingery, Sue Sutter, Bridget Silverman, and Nielsen Hobbs
  
Pink Sheet podcast
Could the FDA determine a legal way to reveal the contents of complete response letters? • Source: Citeline/Shutterstock

More from Podcasts

More from Pink Sheet Perspectives